Tardive Dyskinesia (TD) Treatment Drugs Report

By www.reliablebusinessarena.com

Report Details

Report Name

Global And United States Tardive Dyskinesia (TD) Treatment Drugs Market Report & Forecast 2023-2028 Story

Pages

85

Price

$ 4350

Features

Tardive Dyskinesia (TD) Treatment Drugs Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi